Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OHR Pharmaceutical Inc (NASDAQ:OHRP)

2.96
Delayed Data
As of 4:00pm ET
 +0.07 / +2.42%
Today’s Change
2.02
Today|||52-Week Range
12.31
-51.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Cost of Goods Sold649.3K0.000.000.00
 
 
Depreciation And Amortization87.7K91.1K466.3K1.2M
 
 
 
 
 
 
Operating ExpensesGross Income-737.0K-91.1K-466.3K-1.2M
 
 
 
 
 
General Expenses2.5M4.5M8.7M16.3M
 
 
 
 
 
Research And Development1.5M2.5M3.5M8.8M
 
 
 
 
 
Total Operating Expenses3.3M4.6M9.1M17.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.3M-4.6M-9.1M-17.5M
 
 
 
 
 
Extraordinary Credit1.8M0.000.002.6M
 
 
 
Extraordinary Charge0.00-1.1M0.00-338.9K
 
 
 
Pre-Tax Equity Earnings-----10.6K-103.1K
 
 
 
Interest Expense On Debt1.8K4.7K5.6K6.0K
 
 
 
 
 
Other Expenses112.0090.8K8.5K78.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.5M-5.7M-9.1M-15.2M
 
 
 
 
 
Net Income-1.5M-5.7M-9.1M-15.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.2M18.7M22.1M28.4M
 
 
 
 
 
Shares To Calculate EPS Diluted14.2M18.7M22.1M28.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.30-$0.41-$0.54
 
 
 
 
 
EPS Diluted-$0.09-$0.30-$0.41-$0.54